Reynolds Heidi W, Janowitz Barbara, Homan Rick, Johnson Laura
Health Services Research Division , Family Health International, Research Triangle Park, North Carolina 27709, USA.
Sex Transm Dis. 2006 Jun;33(6):350-6. doi: 10.1097/01.olq.0000194602.01058.e1.
The objective of this study was to highlight the value of preventing unintended pregnancies among HIV-infected women as a strategy to prevent perinatal HIV transmission.
The goal of this study was to assess the cost-effectiveness of family planning programs to avert HIV-positive births with the current programmatic emphasis: prenatal care services that provide and promote nevirapine for prevention of mother-to-child transmission of HIV.
Cost-effectiveness analyses were conducted from the health system perspective during 1 year with a hypothetical sub-Saharan African population. Expected program costs were combined with number of HIV-positive births averted for each strategy.
At the same level of expenditure, the contraceptive strategy averts 28.6% more HIV-positive births than nevirapine for prevention of mother-to-child transmission of HIV.
Increasing contraceptive use among nonusers of contraception who do not want to get pregnant is cost-effective and is an equally important strategy to prevent perinatal transmission as prenatal care programs that provide and promote nevirapine to HIV-infected mothers.
本研究的目的是强调预防感染艾滋病毒的妇女意外怀孕作为预防围产期艾滋病毒传播策略的价值。
本研究的目标是评估计划生育项目在当前项目重点（即提供和推广奈韦拉平以预防艾滋病毒母婴传播的产前护理服务）下避免艾滋病毒阳性婴儿出生的成本效益。
从卫生系统角度对撒哈拉以南非洲的一个假设人群进行了为期1年的成本效益分析。预期项目成本与每种策略避免的艾滋病毒阳性婴儿出生数相结合。
在相同支出水平下，避孕策略比使用奈韦拉平预防艾滋病毒母婴传播多避免28.6%的艾滋病毒阳性婴儿出生。
增加不想怀孕的未使用避孕措施者的避孕措施使用具有成本效益，并且是与向感染艾滋病毒的母亲提供和推广奈韦拉平的产前护理项目同等重要的预防围产期传播策略。
Zotero 插件